Carrick Therapeutics
Latest round
- Series C
Last raised
- Mar 2022
Total raised
- $19M
Investors
- 6
About Carrick Therapeutics
Carrick Therapeutics Ltd is focused on developing oncological therapies, particularly for aggressive and resistant cancers.00 mn from Pfizer Inc. in November 2022.79 mn.Carrick Therapeutics specializes in developing oncological therapies targeting aggressive cancer forms. Key products include Samuraciclib, a CDK7 inhibitor, and CT7439, a CDK12/13 inhibitor, aimed at enhancing the efficacy of existing treatments for advanced breast, prostate, and ovarian cancers, including potential applications for pancreatic and Ewing's sarcoma.Carrick Therapeutics generates revenue through collaborations with pharmaceutical partners and clinical trials. Income is derived from co-development agreements, sharing profits based on the success of clinical trials and subsequent commercialization of products. The company's offerings, including Samuraciclib and CT7439, cater to the oncology market through B2B partnerships with hospitals and healthcare providers, integrating innovative therapies into existing treatment protocols. The company plans to expand its product offerings and market presence, targeting new geographic regions for its therapies. Specific timelines for product launches and regional expansions will be determined as the company progresses.
Who invested in Carrick Therapeutics
6 investors across 1 round
See all investors in Carrick Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Mar 3, 2022
Amount
$19M
Investors
Questions about Carrick Therapeutics
Who invested in Carrick Therapeutics?
Carrick Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Carrick Therapeutics raised?
Carrick Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Carrick Therapeutics last raise money?
Carrick Therapeutics's most recent round on record is a Series C, in Mar 2022.
What does Carrick Therapeutics do?
Carrick Therapeutics Ltd is focused on developing oncological therapies, particularly for aggressive and resistant cancers.
Where is Carrick Therapeutics headquartered?
Carrick Therapeutics is headquartered in Dublin, Ireland.
Which VCs invest in companies like Carrick Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Carrick Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Carrick Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.